Obalon Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Obalon Therapeutics's balance sheet done over the years? Its assets were worth $10,617,000 last year, which is less than in the previous period. 56% of Obalon Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $5,952,000, which means an increase by 31% compared compared to last year.

Debt to Assets

Obalon Therapeutics, Inc. (NASDAQ:OBLN): Debt to assets
2014 20719000 60.57M 292.36%
2015 14221000 69.36M 487.73%
2016 78778000 14.47M 18.37%
2017 53101000 17.98M 33.88%
2018 30386000 17.27M 56.87%
2019 20393000 4.54M 22.28%
2020 10617000 5.95M 56.06%

OBLN Balance Sheet (2014 – 2020)

2020 2019 2018 2017 2016 2015 2014
Assets
Current assets:
Cash and cash equivalents
3.90M14.05M21.18M21.10M72.97M3.35M6.90M
Short term investments
002.54M23.29M2.5M9.17M12.34M
Net receivables
3.15M285K882K4.30M520K661K313K
Inventory
01.93M1.58M1.41M827K363K445K
Other current assets
780K1.95M2.45M1.62M1.23M248K234K
Total current assets
7.83M18.23M28.64M51.75M78.06M13.80M20.23M
Non-current assets:
Property, Plant and Equipment
1.47M2.15M1.73M1.34M717K418K483K
Goodwill
0000000
Intangible assets
0000000
Long term investments
0000000
Other non-current assets
1.30M000000
Total non-current assets
2.78M2.15M1.73M1.34M717K418K483K
Total assets
10.61M20.39M30.38M53.10M78.77M14.22M20.71M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
0424K352K510K000
Short term debt
9.93M09.93M1.95M000
Total current liabilities
5.04M3.97M17.23M10.01M4.59M5.56M872K
Non-current liabilities:
Long term debt
430K007.96M9.88M9.09M4.87M
Deferred tax
0000000
Other non-current liabilities
476K567K48K13K054.69M54.82M
Total non-current liabilities
906K567K48K7.97M9.88M63.79M59.70M
Total liabilities
5.95M4.54M17.27M17.98M14.47M69.36M60.57M
Data sourceData sourceData sourceData sourceData source